Walser B L, Ross-Degnan D, Soumerai S B
Health Aff (Millwood). 1996 Fall;15(3):95-109. doi: 10.1377/hlthaff.15.3.95.
Before 1990 many state Medicaid programs maintained "restrictive" formularies, which denied reimbursement for unlisted prescription drugs. This type of formulary has been criticized for denying important medications to poor, medically needy persons. As part of the Omnibus Budget Reconciliation Act of 1990, restrictive formularies in Medicaid programs were disallowed. Based on research into the 200 top-selling prescription drugs in the United States, we conclude that eliminating Medicaid restrictive formularies improved access to a subset of the 200 best sellers, but that the majority of these products offered only questionable or no additional therapeutic benefit.
1990年以前，许多州的医疗补助计划采用“限制性”处方集，拒绝为未列入的处方药报销费用。这种处方集因拒绝为贫困且有医疗需求的人提供重要药物而受到批评。作为1990年《综合预算协调法案》的一部分，医疗补助计划中的限制性处方集被禁止使用。基于对美国200种最畅销处方药的研究，我们得出结论，取消医疗补助限制性处方集改善了对这200种畅销药中一部分药物的获取，但这些产品中的大多数仅提供了有问题的或没有额外的治疗益处。
